Lonza human and animal hepatocytes for ADME-Tox testing

Friday, 17 March, 2017 | Supplied by: Capsugel Australia Pty Ltd


Lonza now offers a comprehensive portfolio of human and animal hepatocytes for ADME-Tox testing. The range includes both fresh and cryopreserved human and animal hepatocytes, supporting researchers with a variety of in vitro applications, including studies into drug metabolism and toxicity, drug-transporter activity and drug-drug interactions.

The hepatocyte portfolio also features hepatic non-parenchymal cells, such as stellate and Kupffer cells, which can improve the translatability of in vitro toxicity testing and pharmacokinetics research to clinical trials. The hepatocytes are prequalified for a variety of different applications, which helps to reduce time spent evaluating cells for specific experiments within the laboratory.

The range also includes supporting ADME-Tox products such as specialised hepatocyte media and cell culture systems, helping to optimise hepatocyte culture performance for in-vitro drug screening or for research into drug-induced liver injury and other important liver diseases.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

ALA Scientific Instruments RuFus cell unroofing system for plasma membrane isolation

ALA Scientific Instruments offers RuFus, a complete and user-friendly system for performing cell...

Lonza plateable mouse hepatocytes

Lonza provides plateable mouse hepatocytes from the four most common research mouse strains,...

PEPperPRINT cLIFT peptide microarray platform

At the core of the technology is a laser-based transfer process that is designed to deposit amino...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd